ViAqua Therapeutics Overview
- Founded
-
2014
- Status
-
Private
- Employees
-
12
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$4.3M
- Investors
-
8
ViAqua Therapeutics General Information
Description
Developer of an orally administered particle-based platform designed to prevent diseases from developing viral epidemics in aquaculture. The company's platform utilizes a proprietary RNAi nanoparticle formulation that triggers a cellular reaction to disable the viral infection and delivers the coated nanoparticles via feed or immersion, enabling aquaculture industries to improve resistance against viral diseases that attack shrimp and other aquaculture species.
Contact Information
Website
www.viaqua-t.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Aquaculture
Primary Office
- Gutwirth Park
- Technion City
- Haifa 3200003
- Israel
+972 000-000-0000
ViAqua Therapeutics Timeline
ViAqua Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Later Stage VC | 09-Jun-2021 | $4.3M | 00.00 | Completed | Generating Revenue | |
| 3. Early Stage VC | 18-Dec-2018 | 000 | 000 | Completed | Generating Revenue | |
| 2. Early Stage VC | 04-Jul-2018 | Completed | Generating Revenue | |||
| 1. Accelerator/Incubator | Completed | Startup |
ViAqua Therapeutics Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of an orally administered particle-based platform designed to prevent diseases from developing viral epidemics
Biotechnology
Haifa, Israel
12
As of 2022
00.00
0000000000 0
00.00
000000
sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna a
0000 000000000
Leuven, Belgium
00
As of 0000
000.00
00.00
0000-00-00
0000000000 0
000.00
Add Comparison
ViAqua Therapeutics Competitors (1)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| 0000000 | Venture Capital-Backed | Leuven, Belgium | 00 | 000.00 | 0000000000 0 | 000.00 |
ViAqua Therapeutics Patents
ViAqua Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-10973774-B2 | Compositions and methods for treating viral infections in shrimps | Active | 26-Apr-2016 | 0000000000 | 00 |
| US-20190175518-A1 | Compositions and methods for treating viral infections in shrimps | Granted | 26-Apr-2016 | 0000000000 |
ViAqua Therapeutics Executive Team (3)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Shai Ufaz Ph.D | Co-Founder & Chief Executive Officer | ||
| Shai Einbinder Ph.D | Co-Founder & Director | ||
| Dganit Vered | Senior Corporate & R&D Management & Chairman |
ViAqua Therapeutics Board Members (1)
| Name | Representing | Role | Since |
|---|---|---|---|
| Dganit Vered | Self | Senior Corporate & R&D Management & Chairman | 000 0000 |
ViAqua Therapeutics Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
ViAqua Therapeutics Investors (8)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| Agriline | Corporation | Minority | 000 0000 | 000000 0 | |
| S2G Ventures | Venture Capital | Minority | 000 0000 | 000000 0 | |
| Thai Union Group | Corporation | Minority | 000 0000 | 000000 0 | |
| VisVires New Protein | Venture Capital | Minority | 000 0000 | 000000 0 | |
| Israel Innovation Authority | Government | Minority | 000 0000 | 000000 0 |